Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

ConditionAntiphospholipid Syndrome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-18

SponsorUniversity of California, Davis

About this trial

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age or younger at the onset of disease

Presence of Vascular Thrombosis

UC Davis patient

Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Disqualifiers

Infants born to mothers with APS

Infants with congenital thrombophilia

Trial population

Pediatric Nephrology Clinic at University of California, Davis

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

Long term survival

Time frame

10 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, Davis

Lead sponsor

Ministry of Higher Education, Science and Technology, Solvenia

Collaborator

Source ClinicalTrials.gov

Apply now